Endocrinology

Available Courses

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

Mary Korytkowski, MD, describes the effects of diabetes in hospitalized patients with COVID-19.

March 4, 2021

Endocrine-Disrupting Chemicals

Endocrine-Disrupting Chemicals

In this CME, Charity Kwamanakweenda, MD, will discuss how to identify endocrine-disrupting chemicals (EDCs), how to identify endocrine-associated disorders, and how to reduce EDC exposures.

December 12, 2023

Updates in the Management of Osteoporosis

Updates in the Management of Osteoporosis

In this CME, Diana Pinkhasova, MD, discusses following recommended guidelines for management of osteoporosis, increasing patient outcomes with initiation of appropriate pharmacological treatment of osteoporosis, and more.

December 6, 2023

Lipodystrophy: Clinical Approach to Diagnosis and Management

Lipodystrophy: Clinical Approach to Diagnosis and Management

In this CME, Katrina Han, MD, discusses lipodystrophy syndromes and explains how to diagnose, treat, and clinically monitor patients with this condition.

February 28, 2023

Advancing Diabetes Care with Technology

Advancing Diabetes Care with Technology

In this CME, Janet Leung, MD, discusses how to individualize glucose targets in older adults, how to use CGM data to adjust diabetes treatment, and more.

December 21, 2022

Creating Multidisciplinary Teams for Chronic Disease

Creating Multidisciplinary Teams for Chronic Disease

In this CME, Esra Karslioglu French, MD, discusses how to implement multidisciplinary care teams to improve chronic disease outcomes, improve access to subspecialists, and implement integration of APPs to the chronic disease management team.

December 21, 2022

Hyperprolactinemia: A Case-Based Approach

Hyperprolactinemia: A Case-Based Approach

In this presentation, Pouneh Fazeli, MD, MPH, reviews the causes and treatment options for patients with hyperprolactinemia and associated prolactinomas.

May 25, 2022